Home » AI in Drug Discovery Market

AI in Drug Discovery Market By Target Identification and Validation (Predictive Analytics, Biomarker Discovery); By Compound Screening and Design (Virtual Screening, De Novo Drug Design, Generative Chemistry); By ADME-Tox Prediction (Absorption, Distribution, Metabolism, Excretion, Toxicity Modeling); By Clinical Trial Design and Patient Selection (Patient Stratification, Clinical Trial Optimization); By Data Integration and Analysis (Omics Data Integration, Big Data Analytics); By End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutions); By Application Area (Oncology, Neurology, Infectious Diseases); By Region – Growth, Future Prospects & Competitive Analysis, 2023 – 2030

Price: $4999

Published: | Report ID: 32207 | Report Format : PDF

Market Insights

  • The global demand for AI in drug discovery was valued at USD 1684.5 Million in 2022 and is expected to reach USD 14432.2 Million in 2030, growing at a CAGR of 30.8% between 2023 and 2030.
  • The predictive analytics segment is the market leader by target identification and validation, accounting for more than 58% of total value in 2022, while the biomarker discovery segment is likely to grow rapidly over the projection period.
  • The generative chemistry segment is expected to expand rapidly in the forecast period, while the virtual compound screening and design category has the largest share in 2022.
  • Oncology application area dominates the global market need for AI in drug discovery, accounting for more than 38% in 2022, and is predicted to grow at a high CAGR.
  • The pharmaceutical & biotechnology companies category dominated the market with 40% of the total revenue share by end-user. In contrast, the contract research organizations (CROs) segment will expand fastest in the projected time frame.
  • North America contributes to the rapid growth of AI in the drug discovery industry with over one-third of the share in 2022, while Asia Pacific and Europe collectively accounted for just under 54% of the share in 2022. Europe held over 20% market revenue share in 2022.
  • AI is used throughout the drug development process, including hit identification, lead optimization, ADMET prediction (absorption, distribution, metabolism, excretion, and toxicity), and biomarker discovery, demonstrating the market adaptability of AI technologies in the pharmaceutical field.
  • Cloud-based AI solutions are gaining global traction, allowing researchers to access and analyze vast datasets collaboratively. This market trend enhances data sharing and accelerates drug discovery processes.
  • The COVID-19 pandemic highlighted the importance of AI in accelerating drug discovery, with AI models playing an important role in identifying potential treatments and vaccines.

AI in Drug Discovery Market

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Executive Summary

Market Definition

AI in the drug discovery market involves the utilization of artificial intelligence technologies, including machine learning, deep learning, and data analytics. This market applies advanced computational algorithms to analyze extensive biological and chemical datasets, predict potential drug candidates, optimize drug design, and expedite the identification of novel targets for various diseases. The integration of AI in drug discovery aims to enhance efficiency, reduce costs, and accelerate the overall drug development pipeline by leveraging predictive modeling, pattern recognition, and data-driven insights. This transformative approach has the potential to revolutionize the pharmaceutical industry by enabling researchers to make informed decisions and discover innovative therapies with greater precision and speed.

Market Overview

The AI in drug discovery market has witnessed robust growth in recent years and is projected to grow at a CAGR of 30.8% between 2023 and 2030. The global market was valued at USD 1684.5 million in 2022 and is expected to reach USD 14432.2 million in 2030.

AI has captured the attention and views of medical technology practitioners in recent years, as multiple corporations and major research institutions have attempted to improve these technologies for clinical usage. These systems can change how clinicians work and boost productivity while improving treatment and patient throughput. AI for drug discovery is a technology that employs machines to replicate human intelligence to tackle complex problems in the drug development process. Adopting AI technologies in the clinical trial process eliminates potential barriers, reduces clinical trial cycle time, and boosts clinical trial productivity and accuracy. As a result, using these advanced AI systems in drug discovery procedures is gaining traction among stakeholders in the life sciences industry.

It serves the pharmaceutical sector by assisting in the discovery of novel chemicals, the identification of therapeutic targets, and the development of customized drugs. AI platforms used for drug discovery are a viable solution for gaining insights into discovering medications to cure and mitigate the severity of certain chronic conditions. AI allows researchers to use massive volumes of data to discover novel medications. For example, Stanford University researchers discovered that AI systems could analyze over 30 million research articles to identify new medication targets. This simple access to a multitude of data helps researchers to make data-driven decisions and reveal previously unknown insights, leading to ground-breaking discoveries.

Artificial intelligence has the potential to improve medication development success rates. A study published in the journal Nature Biotechnology discovered that AI algorithms have an accuracy of 80% in predicting clinical trial results. The potential of this predictive power to select pharmaceutical candidates who are more likely to succeed increases the possibility of bringing viable medicines to market. According to IQVIA data, AI-powered platforms can reduce the time required for drug discovery by up to 50%. This means that jobs that used to take years to accomplish can now be finished in a fraction of the time.

Segmentation by Target Identification and Validation

  • The biomarker discovery category is positioned to exhibit the largest CAGR. The increasing focus on personalized medicine and identifying reliable disease biomarkers drives the demand for advanced AI-driven biomarker discovery solutions.
  • Currently leading the market share with over 58% in 2022, the predictive analytics segment utilizes sophisticated algorithms to analyze complex biological data, enabling the accurate prediction of potential drug targets. This segment’s dominance is attributed to its proven efficacy in improving target validation processes.

Segmentation by Compound Screening and Design

  • The generative chemistry segment is anticipated to achieve a high CAGR, attributed to the growing adoption of AI in generating novel chemical compounds for drug development. This approach leverages AI algorithms to design molecules with desired properties, expediting the lead optimization process.
  • Leading the market share with over 36% in 2022, the virtual screening segment employs AI to assess large chemical libraries efficiently. This accelerates the identification of potential drug candidates by predicting their binding affinity to specific targets.

Segmentation by ADME-Tox Prediction

  • Absorption dominates the ADME-Tox prediction category, satisfying more than 22% of the global market demand in 2022. AI applications in absorption prediction enhance the understanding of drug bioavailability, a critical factor in optimizing drug formulations for effective delivery.
  • Toxicity modeling is poised to witness the highest CAGR over the upcoming years. AI-driven toxicity prediction models assess the safety profile of compounds, facilitating the early identification of potential adverse effects and contributing to regulatory compliance.

Segmentation by Clinical Trial Design and Patient Selection

  • The clinical trial optimization segment will witness the highest CAGR in the coming years. AI facilitates the design and execution of efficient and adaptive clinical trials, optimizing protocols, patient recruitment, and overall trial management.
  • Patient stratification currently leads the global market share, comprising over 55% in 2022. AI-driven patient stratification enhances the selection of homogenous patient cohorts, improving the likelihood of treatment success in clinical trials and fostering the development of targeted therapies.

Segmentation by Data Integration and Analysis

  • Omics Data Integration emerges as the leading segment, capturing 60% of the market share. This segment involves the comprehensive analysis and integration of various biological data sets, including genomics, proteomics, and metabolomics.
  • Big Data Analytics is recognized as the fastest-growing segment, leveraging AI to process and analyze vast datasets generated from various sources. With its scalability and computational power, this category leads to optimizing research strategies and identifying novel drug candidates.

Segmentation by End-User

  • Pharmaceutical and Biotechnology Companies remain the leading end-user segment, holding 40% of the market share. These industry players leverage AI technologies across the drug development pipeline, from target identification to clinical trial optimization.
  • Contract Research Organizations emerge as the fastest-growing end-user segment. CROs play a key role in supporting drug discovery and development efforts, and AI applications in CROs streamline various services, including preclinical studies, clinical trial design, and data analysis.

Segmentation by Application Area

  • Oncology retains its position as the leading application area, commanding 38% of the market share. AI applications in oncology span a wide spectrum, including tumor profiling, identification of genetic mutations, and prediction of treatment responses.
  • Neurology emerges as the fastest-growing application area. AI technologies perform an essential role in understanding the complex mechanisms of neurological disorders, predicting disease progression, and identifying potential drug targets.
  • Infectious Diseases address the pressing need for innovative solutions in combating infectious agents. AI can rapidly identify potential antiviral or antibacterial compounds, understand host-pathogen interactions, and optimize vaccine development.

Segmentation by Region

  • North America is notably profitable for industry players, accounting for over one-third of the share in 2022, owing to its advanced healthcare infrastructure and substantial investments in AI technologies.
  • Europe and Asia Pacific contributed under 54% of the share in 2022. Europe, with over 20% share, demonstrates a robust market presence due to its developed healthcare systems and growing adoption of AI in drug discovery.
  • The rest of the world, including Latin America, the Middle East, and Africa, fulfills the remaining demand for AI in drug discovery. This represents a potential growth area as awareness and adoption continue expanding in these regions.

AI in Drug Discovery Market Research

A growing global need for the discovery and development of novel drug therapies and the life science industry’s increasing production capacity is driving the market demands for artificial intelligence (AI) enabled solutions in drug discovery processes.

In 2022, North America held the majority of the revenue share of the global AI in the drug discovery market. North America is home to a robust pharmaceutical industry with significant R&D investments, making it an early adopter of AI technologies to accelerate drug discovery. Also, the region boasts a strong ecosystem of AI startups and technology providers specializing in healthcare applications. Moreover, favorable regulatory initiatives, such as the US FDA’s interest in advancing digital health technologies, have encouraged the integration of AI in drug development. The regional access to extensive healthcare databases, academic institutions, and a skilled workforce has further contributed to its leadership in AI-driven drug discovery, attracting substantial investments and fostering innovation in the sector.

Over the projection period, Asia Pacific is expected to be the fastest-growing region. Asia Pacific is witnessing a surge in pharmaceutical and biotechnology research and development activities, making it a ripe market for AI-driven solutions that enhance efficiency and reduce costs. The region also benefits from a burgeoning tech startup ecosystem and increased government support for AI innovation. The availability of vast and diverse regional patient populations and genetic data presents significant opportunities for personalized medicine and drug development. The lower regional operational costs compared to North America and Europe make it an attractive destination for pharmaceutical companies seeking cost-effective AI solutions. These factors collectively position Asia Pacific for rapid growth in AI adoption for drug discovery.

The rise in global prevalence of chronic diseases such as cardiovascular disease, diabetes, respiratory disorders, cancer, and infectious diseases like HIV/AIDS, malaria, and COVID-19 is expected to drive market expansion. For instance, the International Diabetes Federation (IDF) research estimates that 537 million adults (20-79 years) worldwide have diabetes in 2021. Diabetes is expected to affect 643 million people by 2030 and 783 million by 2045. There is an increasing need for artificial intelligence in healthcare as the complexity and diversity of these diseases necessitate novel approaches to drug discovery. AI can also help develop precision medicine methods by personalizing treatments for individual patients based on their unique traits and disease profiles.

Key Highlights of the Report

The AI in the drug discovery market is segmented by target identification and validation, compound screening and design, ADME-Tox prediction, clinical trial design and patient selection, data integration and analysis, end-user, application area, and region. Omics data integration and big data analytics emerge as pivotal tools, with omics data integration claiming a substantial share. Pharmaceutical and biotechnology companies lead as major end-users, leveraging AI to streamline drug discovery processes. Notably, oncology remains a dominant application area, while neurology demonstrates rapid growth.

The increasing prevalence of complicated diseases and the demands for innovative and personalized treatment alternatives propel the market need for more effective and efficient drug discovery procedures. AI can speed drug discovery, improve target identification, and optimize drug development, ultimately discovering innovative and safer medicines. AI advancements in machine learning, deep learning, and natural language processing have considerably increased AI’s abilities to analyze and interpret complicated biological data. These improvements enable the integration of multiple data sources, such as genomes, proteomics, and clinical data, resulting in more complete insights and speedier decision-making in drug discovery.

Regionally, North America, specifically the United States, continues to assert its dominance in the global AI in drug discovery market. This can be attributed to its highly advanced healthcare infrastructure, early adoption of AI technologies, and substantial investments in digital health technologies. On the other hand, the Asia Pacific region, encompassing countries like India and China, presents immense growth potential. Factors such as increased investments, research initiatives, and expanding healthcare access contribute to the regional market’s growth, making it a focal point for industry players and investors.

What Are The Main Drivers Of The Global AI in Drug Discovery Market?

The AI in the drug discovery market is primarily driven by the urgent need for innovative drug candidates, the rising complexity of drug development processes, and the exponential growth of biological and chemical data. AI technologies can significantly accelerate drug discovery by automating data analysis, predicting promising drug candidates, and optimizing various stages of the drug development pipeline. Besides, the COVID-19 pandemic has underscored the importance of AI in rapidly identifying potential treatments, further boosting investment and interest in this market. The collaboration between pharmaceutical companies and AI startups and advancements in machine learning and data analytics continue to fuel the market’s growth and innovation.

What Are The Major Challenges Faced By The Global AI in Drug Discovery Market?

The major challenges AI faces in the drug discovery market include the need for high-quality and diverse datasets, ensuring the interpretability of AI models, addressing regulatory compliance and ethical concerns, integrating AI seamlessly into existing research workflows, and addressing data privacy and security issues. Moreover, the validation and standardization of AI-driven drug discovery approaches and the high upfront costs of implementing AI technology pose major challenges to widespread adoption in the pharmaceutical industry.

What Are The Growth Opportunities In The Global AI in Drug Discovery Market?

The AI in the drug discovery market offers promising growth opportunities, including accelerated drug discovery through AI-driven predictive modeling, personalized medicine tailored to individual patient needs, drug repurposing to identify new therapeutic applications for existing medications, and optimized clinical trial design for enhanced success rates. Besides, expanding AI applications into genomics, proteomics, and metabolomics presents avenues for comprehensive data-driven insights. Collaboration between pharmaceutical companies, AI startups, and academic institutions also promotes innovation while addressing ethical and regulatory challenges will be essential to unlock the full potential of AI in revolutionizing drug discovery and development processes.

Market Drivers

Several factors drive the AI in the drug discovery market. The following are the major global drivers of AI in the drug discovery market:

Increased Efficiency in Drug Discovery

One of the primary drivers of AI in the drug discovery market is the significant improvement in the efficiency of drug discovery processes. Digitalization in biological and clinical research is paving the way for deploying AI solutions. The large number of datasets created during drug development processes, such as the compound screening phase and preclinical research, propels the adoption of AI-powered solutions.

AI-driven tools and algorithms can rapidly analyze vast datasets, including genomics, proteomics, chemical structures, and clinical data, to identify potential drug candidates and anticipate their efficacy. Machine learning (ML) models can learn from historical data to predict which compounds are most likely to succeed, thus reducing the time and resources required for early-stage drug development. This efficiency gains from AI result in quicker identification of promising candidates, faster optimization of lead compounds, and more efficient clinical trial design, ultimately speeding up the entire drug development timeline.

Market Restraints

AI in the drug discovery market faces challenges that impede its growth. These consist of the following:

Data Quality and Quantity Challenges

A key restraint in AI in the drug discovery market is data availability and quality. AI models rely heavily on large and diverse datasets to train effectively. However, obtaining high-quality, well-annotated, and comprehensive datasets can be challenging in drug discovery. Data in the life sciences often come from various sources, including clinical trials, research studies, and real-world patient data, each with limitations and biases. Moreover, data privacy concerns and regulatory restrictions can hinder data sharing and collaboration. The scarcity of high-quality data limits the accuracy and generalizability of AI models, potentially leading to erroneous predictions and inefficiencies in the drug discovery process.

Opportunities

AI in the drug discovery market offers major growth opportunities. These consist of the following:

Personalized Medicine and Targeted Therapies

AI in drug discovery enables the development of personalized medicine and targeted therapies, representing a promising opportunity. Personalized medicine entails tailoring medical treatments to individual patient profiles, considering genetic, molecular, and clinical data. AI algorithms can analyze a patient’s genetic information, biomarkers, and health history to identify the most effective treatment options, predict drug responses, and minimize adverse effects. This approach enhances patient outcomes and allows pharmaceutical companies to create more specialized and high-value therapies. As the understanding of genomics and molecular biology advances, AI-driven personalized medicine is expected to play a major role in improving healthcare and expanding the market for precision therapies.

Competitive Landscape

AI in Drug Discovery Market Report

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key Players

The AI in the drug discovery market features a dynamic competitive landscape characterized by established pharmaceutical companies, innovative startups, technology providers, and research institutions. The following are some of the top market players and their market shares:

  • Microsoft
  • BenevolentAI
  • Excientia
  • IBM Corporation
  • Alphabet (DeepMind)
  • Others

These market leaders are focusing on developing proprietary AI algorithms, building extensive databases, and forging partnerships to stay ahead in the race to deliver cutting-edge AI-driven drug discovery solutions. Established players such as Pfizer, Novartis, and GlaxoSmithKline are heavily investing in AI technologies and forming strategic partnerships with AI startups to enhance their drug discovery capabilities. Meanwhile, startups like Insilico Medicine, BenevolentAI, and Atomwise are gaining market prominence with cutting-edge AI algorithms and platforms. Technology providers like IBM Watson Health and Google’s DeepMind also contribute AI-driven market solutions.

In May 2023, Google Cloud released two new AI-powered tools, the Target & Lead Identification Suite and the Multiomics Suite, to help biotech, pharmaceutical, and public sector organizations speed up drug development and precision medicine. The Target and Lead Identification Suite accelerates drug discovery optimization by enabling more efficient in-silico drug design, protein structures, and protein structures.

In May 2023, BenevolentAI has partnered with 9xchange. The collaboration aims to use BenevolentAI’s AI-enabled technology to improve decision-making for assets on the 9xchange platform relating to indication expansion and drug repurposing. The partnership’s goal was to find unrealized potential in therapeutic portfolios and open up new avenues for drug discovery by merging the 9xchange platform with BenevolentAI’s established AI-enabled engine.

In March 2023, NVIDIA introduced the BioNeMo Cloud service, which expands its generative AI cloud solutions to enable drug development and research in genomics, biology, chemistry, and molecular dynamics. The BioNeMo Cloud service enables researchers to fine-tune AI applications on their proprietary data and execute AI model inference in web browsers or cloud APIs.

In November 2022, Exscientia partnered with the University of Texas MD Anderson Cancer Centre to deploy its patient-centric AI platform for innovative small molecule medication discovery and development, leveraging MD Anderson’s expertise. This strategy benefited the company’s expansion and growth.

Summary of Key Findings

  • The global AI in drug discovery market has experienced rapid growth over recent years, owing to the increasing adoption of artificial intelligence and machine learning technologies across the pharmaceutical and biotechnology sectors.
  • Market segmented by target identification and validation, compound screening and design, ADME-Tox prediction, clinical trial design and patient selection, data integration and analysis, end-user, application area, and region.
  • AI plays a crucial role in target identification and validation, helping researchers identify novel drug targets more accurately and providing insights into their therapeutic potential.
  • AI algorithms assist in lead optimization by predicting the most promising drug candidates, optimizing chemical structures, and improving the likelihood of successful drug development.
  • AI-driven platforms enhance hit identification by efficiently screening and analyzing large compound libraries, improving the chances of identifying compounds with therapeutic potential.
  • AI in drug discovery is applied across various therapeutic areas, including oncology, neurology, cardiovascular diseases, and rare diseases, addressing a wide spectrum of healthcare needs.
  • Market challenges in data quality, privacy, and interpretability of AI models are still barriers to its wider adoption.

Future Outlook

  • The Asia Pacific region, especially China and India, continues to experience significant growth in AI adoption for drug discovery, driven by increased investments and research initiatives.
  • AI in drug discovery will extend beyond early-stage research into clinical trial optimization, drug repurposing, and post-market surveillance, broadening its impact across the drug development lifecycle.
  • AI in drug discovery will profoundly impact global health, potentially addressing unmet medical needs and improving access to innovative treatments.
  • The adoption of AI in drug discovery is not limited to specific regions, with a global expansion of AI-driven initiatives. Pharmaceutical companies and research institutions worldwide are integrating AI technologies into their drug discovery workflows.

Segmentation

  • By Target Identification and Validation
    • Predictive Analytics
    • Biomarker Discovery
  • By Compound Screening and Design
    • Virtual Screening
    • De Novo Drug Design
    • Generative Chemistry
  • By ADME-Tox Prediction
    • Absorption
    • Distribution
    • Metabolism
    • Excretion
    • Toxicity Modeling
  • By Clinical Trial Design and Patient Selection
    • Patient Stratification
    • Clinical Trial Optimization
  • By Data Integration and Analysis
    • Omics Data Integration
    • Big Data Analytics
  • By End-User
    • Pharmaceutical and Biotechnology Companies
    • Contract Research Organizations (CROs)
    • Academic and Research Institutions
  • By Application Area
    • Oncology
    • Neurology
    • Infectious Diseases
  • By Region
    • North America
      • The U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • The U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • South-east Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of the Middle East and Africa

Table of Content
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: Global AI in Drug Discovery Market
2.1.1. Global AI in Drug Discovery Market, By Target Identification and Validation
2.1.2. Global AI in Drug Discovery Market, By Compound Screening and Design
2.1.3. Global AI in Drug Discovery Market, By ADME-Tox Prediction
2.1.4. Global AI in Drug Discovery Market, By Clinical Trial Design and Patient Selection
2.1.5. Global AI in Drug Discovery Market, By Data Integration and Analysis
2.1.6. Global AI in Drug Discovery Market, By End-User
2.1.7. Global AI in Drug Discovery Market, By Application Area
2.1.8. Global AI in Drug Discovery Market, By Region
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global AI in Drug Discovery Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. AI in Drug Discovery Market Drivers
3.2.2. AI in Drug Discovery Market Restraints
3.2.3. AI in Drug Discovery Market Opportunities
3.2.4. Major AI in Drug Discovery Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Target Identification and Validation
3.5.2. Compound Screening and Design
3.5.3. ADME-Tox Prediction
3.5.4. Clinical Trial Design and Patient Selection
3.5.5. Data Integration and Analysis
3.5.6. End-User
3.5.7. Application Area
3.5.8. Geography
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global AI in Drug Discovery Market: Company Market Share, Value 2022
4.1.2. Global AI in Drug Discovery Market: Top 6 Company Market Share, Value 2022
4.1.3. Global AI in Drug Discovery Market: Top 3 Company Market Share, Value 2022
4.2. Global AI in Drug Discovery Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Product Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Product Matrix
4.7. Potential for New Players in the Global AI in Drug Discovery Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Research and development in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Product Launch
6.5.5. Geographical Expansion
6.5.6. Others
7. Impact Analysis of COVID-19 and Russia – Ukraine War on AI in Drug Discovery Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Product Mix
7.2.4. Reduced Industrial Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa
8. Global AI in Drug Discovery Market, By Target Identification and Validation
8.1. Global AI in Drug Discovery Market Overview, by Target Identification and Validation
8.1.1. Global AI in Drug Discovery Market Revenue Share, By Target Identification and Validation, 2022 Vs 2030 (in %)
8.2. Predictive Analytics
8.2.1. Global AI in Drug Discovery Market, By Predictive Analytics, By Region, 2017-2030 (US$ Mn)
8.2.2. Market Dynamics for Predictive Analytics
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Biomarker Discovery
8.3.1. Global AI in Drug Discovery Market, By Biomarker Discovery, By Region, 2017-2030 (US$ Mn)
8.3.2. Market Dynamics for Biomarker Discovery
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
9. Global AI in Drug Discovery Market, By Compound Screening and Design
9.1. Global AI in Drug Discovery Market Overview, by Compound Screening and Design
9.1.1. Global AI in Drug Discovery Market Revenue Share, By Compound Screening and Design, 2022 Vs 2030 (in %)
9.2. Virtual Screening
9.2.1. Global AI in Drug Discovery Market, By Virtual Screening, By Region, 2017-2030 (US$ Mn)
9.2.2. Market Dynamics for Virtual Screening
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. De Novo Drug Design
9.3.1. Global AI in Drug Discovery Market, By De Novo Drug Design, By Region, 2017-2030 (US$ Mn)
9.3.2. Market Dynamics for De Novo Drug Design
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
9.4. Generative Chemistry
9.4.1. Global AI in Drug Discovery Market, By Generative Chemistry, By Region, 2017-2030 (US$ Mn)
9.4.2. Market Dynamics for Generative Chemistry
9.4.2.1. Drivers
9.4.2.2. Restraints
9.4.2.3. Opportunities
9.4.2.4. Trends
10. Global AI in Drug Discovery Market, By ADME-Tox Prediction
10.1. Global AI in Drug Discovery Market Overview, by ADME-Tox Prediction
10.1.1. Global AI in Drug Discovery Market Revenue Share, By ADME-Tox Prediction, 2022 Vs 2030 (in %)
10.2. Absorption
10.2.1. Global AI in Drug Discovery Market, By Absorption, By Region, 2017-2030 (US$ Mn)
10.2.2. Market Dynamics for Absorption
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Distribution
10.3.1. Global AI in Drug Discovery Market, By Distribution, By Region, 2017-2030 (US$ Mn)
10.3.2. Market Dynamics for Distribution
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
10.4. Metabolism
10.4.1. Global AI in Drug Discovery Market, By Metabolism, By Region, 2017-2030 (US$ Mn)
10.4.2. Market Dynamics for Metabolism
10.4.2.1. Drivers
10.4.2.2. Restraints
10.4.2.3. Opportunities
10.4.2.4. Trends
10.5. Excretion
10.5.1. Global AI in Drug Discovery Market, By Excretion, By Region, 2017-2030 (US$ Mn)
10.5.2. Market Dynamics for Excretion
10.5.2.1. Drivers
10.5.2.2. Restraints
10.5.2.3. Opportunities
10.5.2.4. Trends
10.6. Toxicity Modeling
10.6.1. Global AI in Drug Discovery Market, By Toxicity Modeling, By Region, 2017-2030 (US$ Mn)
10.6.2. Market Dynamics for Toxicity Modeling
10.6.2.1. Drivers
10.6.2.2. Restraints
10.6.2.3. Opportunities
10.6.2.4. Trends
11. Global AI in Drug Discovery Market, By Clinical Trial Design and Patient Selection
11.1. Global AI in Drug Discovery Market Overview, by Clinical Trial Design and Patient Selection
11.1.1. Global AI in Drug Discovery Market Revenue Share, By Clinical Trial Design and Patient Selection, 2022 Vs 2030 (in %)
11.2. Patient Stratification
11.2.1. Global AI in Drug Discovery Market, By Patient Stratification, By Region, 2017-2030 (US$ Mn)
11.2.2. Market Dynamics for Patient Stratification
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. Clinical Trial Optimization
11.3.1. Global AI in Drug Discovery Market, By Clinical Trial Optimization, By Region, 2017-2030 (US$ Mn)
11.3.2. Market Dynamics for Clinical Trial Optimization
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends
12. Global AI in Drug Discovery Market, By Data Integration and Analysis
12.1. Global AI in Drug Discovery Market Overview, by Data Integration and Analysis
12.1.1. Global AI in Drug Discovery Market Revenue Share, By Data Integration and Analysis, 2022 Vs 2030 (in %)
12.2. Omics Data Integration
12.2.1. Global AI in Drug Discovery Market, By Omics Data Integration, By Region, 2017-2030 (US$ Mn)
12.2.2. Market Dynamics for Omics Data Integration
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
12.3. Big Data Analytics
12.3.1. Global AI in Drug Discovery Market, By Big Data Analytics, By Region, 2017-2030 (US$ Mn)
12.3.2. Market Dynamics for Big Data Analytics
12.3.2.1. Drivers
12.3.2.2. Restraints
12.3.2.3. Opportunities
12.3.2.4. Trends
13. Global AI in Drug Discovery Market, By End-User
13.1. Global AI in Drug Discovery Market Overview, by End-User
13.1.1. Global AI in Drug Discovery Market Revenue Share, By End-User, 2022 Vs 2030 (in %)
13.2. Pharmaceutical and Biotechnology Companies
13.2.1. Global AI in Drug Discovery Market, By Pharmaceutical and Biotechnology Companies, By Region, 2017-2030 (US$ Mn)
13.2.2. Market Dynamics for Pharmaceutical and Biotechnology Companies
13.2.2.1. Drivers
13.2.2.2. Restraints
13.2.2.3. Opportunities
13.2.2.4. Trends
13.3. Contract Research Organizations (CROs)
13.3.1. Global AI in Drug Discovery Market, By Contract Research Organizations (CROs), By Region, 2017-2030 (US$ Mn)
13.3.2. Market Dynamics for Contract Research Organizations (CROs)
13.3.2.1. Drivers
13.3.2.2. Restraints
13.3.2.3. Opportunities
13.3.2.4. Trends
13.4. Academic and Research Institutions
13.4.1. Global AI in Drug Discovery Market, By Academic and Research Institutions, By Region, 2017-2030 (US$ Mn)
13.4.2. Market Dynamics for Academic and Research Institutions
13.4.2.1. Drivers
13.4.2.2. Restraints
13.4.2.3. Opportunities
13.4.2.4. Trends
14. Global AI in Drug Discovery Market, By Application Area
14.1. Global AI in Drug Discovery Market Overview, by Application Area
14.1.1. Global AI in Drug Discovery Market Revenue Share, By Application Area, 2022 Vs 2030 (in %)
14.2. Oncology
14.2.1. Global AI in Drug Discovery Market, By Oncology, By Region, 2017-2030 (US$ Mn)
14.2.2. Market Dynamics for Oncology
14.2.2.1. Drivers
14.2.2.2. Restraints
14.2.2.3. Opportunities
14.2.2.4. Trends
14.3. Neurology
14.3.1. Global AI in Drug Discovery Market, By Neurology, By Region, 2017-2030 (US$ Mn)
14.3.2. Market Dynamics for Neurology
14.3.2.1. Drivers
14.3.2.2. Restraints
14.3.2.3. Opportunities
14.3.2.4. Trends
14.4. Infectious Diseases
14.4.1. Global AI in Drug Discovery Market, By Infectious Diseases, By Region, 2017-2030 (US$ Mn)
14.4.2. Market Dynamics for Infectious Diseases
14.4.2.1. Drivers
14.4.2.2. Restraints
14.4.2.3. Opportunities
14.4.2.4. Trends
15. Global AI in Drug Discovery Market, By Region
15.1. Global AI in Drug Discovery Market Overview, by Region
15.1.1. Global AI in Drug Discovery Market, By Region, 2022 vs 2030 (in%)
15.2. Target Identification and Validation
15.2.1. Global AI in Drug Discovery Market, By Target Identification and Validation, 2017-2030 (US$ Mn)
15.3. Compound Screening and Design
15.3.1. Global AI in Drug Discovery Market, By Compound Screening and Design, 2017-2030 (US$ Mn)
15.4. ADME-Tox Prediction
15.4.1. Global AI in Drug Discovery Market, By ADME-Tox Prediction, 2017-2030 (US$ Mn)
15.5. Clinical Trial Design and Patient Selection
15.5.1. Global AI in Drug Discovery Market, By Clinical Trial Design and Patient Selection, 2017-2030 (US$ Mn)
15.6. Data Integration and Analysis
15.6.1. Global AI in Drug Discovery Market, By Data Integration and Analysis, 2017-2030 (US$ Mn)
15.7. End-User
15.7.1. Global AI in Drug Discovery Market, By End-User, 2017-2030 (US$ Mn)
15.8. Application Area
15.8.1. Global AI in Drug Discovery Market, By Application Area, 2017-2030 (US$ Mn)
16. North America AI in Drug Discovery Market Analysis
16.1. Overview
16.1.1. Market Dynamics for North America
16.1.1.1. Drivers
16.1.1.2. Restraints
16.1.1.3. Opportunities
16.1.1.4. Trends
16.2. North America AI in Drug Discovery Market, by Target Identification and Validation, 2017-2030(US$ Mn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. North America AI in Drug Discovery Market, by Compound Screening and Design, 2017-2030(US$ Mn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. North America AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2030(US$ Mn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. North America AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, 2017-2030(US$ Mn)
16.5.1. Overview
16.5.2. SRC Analysis
16.6. North America AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2030(US$ Mn)
16.6.1. Overview
16.6.2. SRC Analysis
16.7. North America AI in Drug Discovery Market, by End-User, 2017-2030(US$ Mn)
16.7.1. Overview
16.7.2. SRC Analysis
16.8. North America AI in Drug Discovery Market, by Application Area, 2017-2030(US$ Mn)
16.8.1. Overview
16.8.2. SRC Analysis
16.9. North America AI in Drug Discovery Market, by Country, 2017-2030 (US$ Mn)
16.9.1. North America AI in Drug Discovery Market, by Country, 2022 Vs 2030 (in%)
16.9.2. U.S.
16.9.3. Canada
16.9.4. Mexico
17. Europe AI in Drug Discovery Market Analysis
17.1. Overview
17.1.1. Market Dynamics for North America
17.1.1.1. Drivers
17.1.1.2. Restraints
17.1.1.3. Opportunities
17.1.1.4. Trends
17.2. Europe AI in Drug Discovery Market, by Target Identification and Validation, 2017-2030(US$ Mn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. Europe AI in Drug Discovery Market, by Compound Screening and Design, 2017-2030(US$ Mn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. Europe AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2030(US$ Mn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. Europe AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, 2017-2030(US$ Mn)
17.5.1. Overview
17.5.2. SRC Analysis
17.6. Europe AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2030(US$ Mn)
17.6.1. Overview
17.6.2. SRC Analysis
17.7. Europe AI in Drug Discovery Market, by End-User, 2017-2030(US$ Mn)
17.7.1. Overview
17.7.2. SRC Analysis
17.8. Europe AI in Drug Discovery Market, by Application Area, 2017-2030(US$ Mn)
17.8.1. Overview
17.8.2. SRC Analysis
17.9. Europe AI in Drug Discovery Market, by Country, 2017-2030 (US$ Mn)
17.9.1. Europe AI in Drug Discovery Market, by Country, 2022 Vs 2030 (in%)
17.9.2. UK
17.9.3. France
17.9.4. Germany
17.9.5. Italy
17.9.6. Spain
17.9.7. Benelux
17.9.8. Russia
17.9.9. Rest of Europe
18. Asia Pacific AI in Drug Discovery Market Analysis
18.1. Overview
18.1.1. Market Dynamics for North America
18.1.1.1. Drivers
18.1.1.2. Restraints
18.1.1.3. Opportunities
18.1.1.4. Trends
18.2. Asia Pacific AI in Drug Discovery Market, by Target Identification and Validation, 2017-2030(US$ Mn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. Asia Pacific AI in Drug Discovery Market, by Compound Screening and Design, 2017-2030(US$ Mn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. Asia Pacific AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2030(US$ Mn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. Asia Pacific AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, 2017-2030(US$ Mn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. Asia Pacific AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2030(US$ Mn)
18.6.1. Overview
18.6.2. SRC Analysis
18.7. Asia Pacific AI in Drug Discovery Market, by End-User, 2017-2030(US$ Mn)
18.7.1. Overview
18.7.2. SRC Analysis
18.8. Asia Pacific AI in Drug Discovery Market, by Application Area, 2017-2030(US$ Mn)
18.8.1. Overview
18.8.2. SRC Analysis
18.9. Asia Pacific AI in Drug Discovery Market, by Country, 2017-2030 (US$ Mn)
18.9.1. Asia Pacific AI in Drug Discovery Market, by Country, 2022 Vs 2030 (in%)
18.9.2. China
18.9.3. Japan
18.9.4. India
18.9.5. South Korea
18.9.6. South East Asia
18.9.7. Rest of Asia Pacific
19. Latin America AI in Drug Discovery Market Analysis
19.1. Overview
19.1.1. Market Dynamics for North America
19.1.1.1. Drivers
19.1.1.2. Restraints
19.1.1.3. Opportunities
19.1.1.4. Trends
19.2. Latin America AI in Drug Discovery Market, by Target Identification and Validation, 2017-2030(US$ Mn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. Latin America AI in Drug Discovery Market, by Compound Screening and Design, 2017-2030(US$ Mn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. Latin America AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2030(US$ Mn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. Latin America AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, 2017-2030(US$ Mn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. Latin America AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2030(US$ Mn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. Latin America AI in Drug Discovery Market, by End-User, 2017-2030(US$ Mn)
19.7.1. Overview
19.7.2. SRC Analysis
19.8. Latin America AI in Drug Discovery Market, by Application Area, 2017-2030(US$ Mn)
19.8.1. Overview
19.8.2. SRC Analysis
19.9. Latin America AI in Drug Discovery Market, by Country, 2017-2030 (US$ Mn)
19.9.1. Latin America AI in Drug Discovery Market, by Country, 2022 Vs 2030 (in%)
19.9.2. Brazil
19.9.3. Argentina
19.9.4. Rest of Latin America
20. Middle East AI in Drug Discovery Market Analysis
20.1. Overview
20.1.1. Market Dynamics for North America
20.1.1.1. Drivers
20.1.1.2. Restraints
20.1.1.3. Opportunities
20.1.1.4. Trends
20.2. Middle East AI in Drug Discovery Market, by Target Identification and Validation, 2017-2030(US$ Mn)
20.2.1. Overview
20.2.2. SRC Analysis
20.3. Middle East AI in Drug Discovery Market, by Compound Screening and Design, 2017-2030(US$ Mn)
20.3.1. Overview
20.3.2. SRC Analysis
20.4. Middle East AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2030(US$ Mn)
20.4.1. Overview
20.4.2. SRC Analysis
20.5. Middle East AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, 2017-2030(US$ Mn)
20.5.1. Overview
20.5.2. SRC Analysis
20.6. Middle East AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2030(US$ Mn)
20.6.1. Overview
20.6.2. SRC Analysis
20.7. Middle East AI in Drug Discovery Market, by End-User, 2017-2030(US$ Mn)
20.7.1. Overview
20.7.2. SRC Analysis
20.8. Middle East AI in Drug Discovery Market, by Application Area, 2017-2030(US$ Mn)
20.8.1. Overview
20.8.2. SRC Analysis
20.9. Middle East AI in Drug Discovery Market, by Country, 2017-2030 (US$ Mn)
20.9.1. Middle East AI in Drug Discovery Market, by Country, 2022 Vs 2030 (in%)
20.9.2. UAE
20.9.3. Saudi Arabia
20.9.4. Rest of Middle East
21. Africa AI in Drug Discovery Market Analysis
21.1. Overview
21.1.1. Market Dynamics for North America
21.1.1.1. Drivers
21.1.1.2. Restraints
21.1.1.3. Opportunities
21.1.1.4. Trends
21.2. Africa AI in Drug Discovery Market, by Target Identification and Validation, 2017-2030(US$ Mn)
21.2.1. Overview
21.2.2. SRC Analysis
21.3. Africa AI in Drug Discovery Market, by Compound Screening and Design, 2017-2030(US$ Mn)
21.3.1. Overview
21.3.2. SRC Analysis
21.4. Africa AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2030(US$ Mn)
21.4.1. Overview
21.4.2. SRC Analysis
21.5. Africa AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, 2017-2030(US$ Mn)
21.5.1. Overview
21.5.2. SRC Analysis
21.6. Africa AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2030(US$ Mn)
21.6.1. Overview
21.6.2. SRC Analysis
21.7. Africa AI in Drug Discovery Market, by End-User, 2017-2030(US$ Mn)
21.7.1. Overview
21.7.2. SRC Analysis
21.8. Africa AI in Drug Discovery Market, by Application Area, 2017-2030(US$ Mn)
21.8.1. Overview
21.8.2. SRC Analysis
21.9. Africa AI in Drug Discovery Market, by Country, 2017-2030 (US$ Mn)
21.9.1. Middle East AI in Drug Discovery Market, by Country, 2022 Vs 2030 (in%)
21.9.2. South Africa
21.9.3. Egypt
21.9.4. Rest of Africa
22. Company Profiles
22.1. Microsoft
22.1.1. Company Overview
22.1.2. Products/Services Portfolio
22.1.3. Geographical Presence
22.1.4. SWOT Analysis
22.1.5. Financial Summary
22.1.5.1. Market Revenue and Net Profit (2019-2022)
22.1.5.2. Business Segment Revenue Analysis
22.1.5.3. Geographical Revenue Analysis
22.2. BenevolentAI
22.3. Excientia
22.4. IBM Corporation
22.5. Alphabet (DeepMind)
22.6. Others
23. Research Methodology
23.1. Research Methodology
23.2. Phase I – Secondary Research
23.3. Phase II – Data Modelling
23.3.1. Company Share Analysis Model
23.3.2. Revenue Based Modelling
23.4. Phase III – Primary Research
23.5. Research Limitations
23.5.1. Assumptions

List of Figures
FIG. 1 Global AI in Drug Discovery Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom Up Approach
FIG. 3 Global AI in Drug Discovery Market Segmentation
FIG. 4 Global AI in Drug Discovery Market, by Target Identification and Validation, 2022 (US$ Mn)
FIG. 5 Global AI in Drug Discovery Market, by Compound Screening and Design, 2022 (US$ Mn)
FIG. 6 Global AI in Drug Discovery Market, by ADME-Tox Prediction, 2022 (US$ Mn)
FIG. 7 Global AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, 2022 (US$ Mn)
FIG. 8 Global AI in Drug Discovery Market, by Data Integration and Analysis, 2022 (US$ Mn)
FIG. 9 Global AI in Drug Discovery Market, by End-User, 2022 (US$ Mn)
FIG. 10 Global AI in Drug Discovery Market, by Application Area, 2022 (US$ Mn)
FIG. 11 Global AI in Drug Discovery Market, by Geography, 2022 (US$ Mn)
FIG. 12 Attractive Investment Proposition, by Target Identification and Validation, 2022
FIG. 13 Attractive Investment Proposition, by Compound Screening and Design, 2022
FIG. 14 Attractive Investment Proposition, by ADME-Tox Prediction, 2022
FIG. 15 Attractive Investment Proposition, by Clinical Trial Design and Patient Selection, 2022
FIG. 16 Attractive Investment Proposition, by Data Integration and Analysis, 2022
FIG. 17 Attractive Investment Proposition, by End-User, 2022
FIG. 18 Attractive Investment Proposition, by Application Area, 2022
FIG. 19 Attractive Investment Proposition, by Geography, 2022
FIG. 20 Global Market Share Analysis of Key AI in Drug Discovery Market Manufacturers, 2022
FIG. 21 Global Market Positioning of Key AI in Drug Discovery Market Manufacturers, 2022
FIG. 22 Global AI in Drug Discovery Market Value Contribution, By Target Identification and Validation, 2022 & 2030 (Value %)
FIG. 23 Global AI in Drug Discovery Market, by Predictive Analytics, Value, 2017-2030 (US$ Mn)
FIG. 24 Global AI in Drug Discovery Market, by Biomarker Discovery, Value, 2017-2030 (US$ Mn)
FIG. 25 Global AI in Drug Discovery Market Value Contribution, By Compound Screening and Design, 2022 & 2030 (Value %)
FIG. 26 Global AI in Drug Discovery Market, by Virtual Screening, Value, 2017-2030 (US$ Mn)
FIG. 27 Global AI in Drug Discovery Market, by De Novo Drug Design, Value, 2017-2030 (US$ Mn)
FIG. 28 Global AI in Drug Discovery Market, by Generative Chemistry, Value, 2017-2030 (US$ Mn)
FIG. 29 Global AI in Drug Discovery Market Value Contribution, By ADME-Tox Prediction, 2022 & 2030 (Value %)
FIG. 30 Global AI in Drug Discovery Market, by Absorption, Value, 2017-2030 (US$ Mn)
FIG. 31 Global AI in Drug Discovery Market, by Distribution, Value, 2017-2030 (US$ Mn)
FIG. 32 Global AI in Drug Discovery Market, by Metabolism, Value, 2017-2030 (US$ Mn)
FIG. 33 Global AI in Drug Discovery Market, by Excretion, Value, 2017-2030 (US$ Mn)
FIG. 34 Global AI in Drug Discovery Market, by Toxicity Modeling, Value, 2017-2030 (US$ Mn)
FIG. 35 Global AI in Drug Discovery Market Value Contribution, By Clinical Trial Design and Patient Selection, 2022 & 2030 (Value %)
FIG. 36 Global AI in Drug Discovery Market, by Patient Stratification, Value, 2017-2030 (US$ Mn)
FIG. 37 Global AI in Drug Discovery Market, by Clinical Trial Optimization, Value, 2017-2030 (US$ Mn)
FIG. 38 Global AI in Drug Discovery Market Value Contribution, By Data Integration and Analysis, 2022 & 2030 (Value %)
FIG. 39 Global AI in Drug Discovery Market, by Omics Data Integration, Value, 2017-2030 (US$ Mn)
FIG. 40 Global AI in Drug Discovery Market, by Big Data Analytics, Value, 2017-2030 (US$ Mn)
FIG. 41 Global AI in Drug Discovery Market Value Contribution, By End-User, 2022 & 2030 (Value %)
FIG. 42 Global AI in Drug Discovery Market, by Pharmaceutical and Biotechnology Companies, Value, 2017-2030 (US$ Mn)
FIG. 43 Global AI in Drug Discovery Market, by Contract Research Organizations (CROs), Value, 2017-2030 (US$ Mn)
FIG. 44 Global AI in Drug Discovery Market, by Academic and Research Institutions, Value, 2017-2030 (US$ Mn)
FIG. 45 Global AI in Drug Discovery Market Value Contribution, By Application Area, 2022 & 2030 (Value %)
FIG. 46 Global AI in Drug Discovery Market, by Oncology, Value, 2017-2030 (US$ Mn)
FIG. 47 Global AI in Drug Discovery Market, by Neurology, Value, 2017-2030 (US$ Mn)
FIG. 48 Global AI in Drug Discovery Market, by Infectious Diseases, Value, 2017-2030 (US$ Mn)
FIG. 49 North America AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 50 U.S. AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 51 Canada AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 52 Mexico AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 53 Europe AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 54 Germany AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 55 France AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 56 U.K. AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 57 Italy AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 58 Spain AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 59 Benelux AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 60 Russia AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 61 Rest of Europe AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 62 Asia Pacific AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 63 China AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 64 Japan AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 65 India AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 66 South Korea AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 67 South-East Asia AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 68 Rest of Asia Pacific AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 69 Latin America AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 70 Brazil AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 71 Argentina AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 72 Rest of Latin America AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 73 Middle East AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 74 UAE AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 75 Saudi Arabia AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 76 Rest of Middle East AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 77 Africa AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 78 South Africa AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 79 Egypt AI in Drug Discovery Market, 2017-2030 (US$ Mn)
FIG. 80 Rest of Africa AI in Drug Discovery Market, 2017-2030 (US$ Mn)

List of Tables
TABLE 1 Market Snapshot: Global AI in Drug Discovery Market
TABLE 2 Global AI in Drug Discovery Market: Market Drivers Impact Analysis
TABLE 3 Global AI in Drug Discovery Market: Market Restraints Impact Analysis
TABLE 4 Global AI in Drug Discovery Market, by Competitive Benchmarking, 2022
TABLE 5 Global AI in Drug Discovery Market, by Geographical Presence Analysis, 2022
TABLE 6 Global AI in Drug Discovery Market, by Key Strategies Analysis, 2022
TABLE 7 Global AI in Drug Discovery Market, by Predictive Analytics, By Region, 2017-2022 (US$ Mn)
TABLE 8 Global AI in Drug Discovery Market, by Predictive Analytics, By Region, 2023-2030 (US$ Mn)
TABLE 9 Global AI in Drug Discovery Market, by Biomarker Discovery, By Region, 2017-2022 (US$ Mn)
TABLE 10 Global AI in Drug Discovery Market, by Biomarker Discovery, By Region, 2023-2030 (US$ Mn)
TABLE 11 Global AI in Drug Discovery Market, by Virtual Screening, By Region, 2017-2022 (US$ Mn)
TABLE 12 Global AI in Drug Discovery Market, by Virtual Screening, By Region, 2023-2030 (US$ Mn)
TABLE 13 Global AI in Drug Discovery Market, by De Novo Drug Design, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global AI in Drug Discovery Market, by De Novo Drug Design, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global AI in Drug Discovery Market, by Generative Chemistry, By Region, 2017-2022 (US$ Mn)
TABLE 16 Global AI in Drug Discovery Market, by Generative Chemistry, By Region, 2023-2030 (US$ Mn)
TABLE 17 Global AI in Drug Discovery Market, by Absorption, By Region, 2017-2022 (US$ Mn)
TABLE 18 Global AI in Drug Discovery Market, by Absorption, By Region, 2023-2030 (US$ Mn)
TABLE 19 Global AI in Drug Discovery Market, by Distribution, By Region, 2017-2022 (US$ Mn)
TABLE 20 Global AI in Drug Discovery Market, by Distribution, By Region, 2023-2030 (US$ Mn)
TABLE 21 Global AI in Drug Discovery Market, by Metabolism, By Region, 2017-2022 (US$ Mn)
TABLE 22 Global AI in Drug Discovery Market, by Metabolism, By Region, 2023-2030 (US$ Mn)
TABLE 23 Global AI in Drug Discovery Market, by Excretion, By Region, 2017-2022 (US$ Mn)
TABLE 24 Global AI in Drug Discovery Market, by Excretion, By Region, 2023-2030 (US$ Mn)
TABLE 25 Global AI in Drug Discovery Market, by Toxicity Modeling, By Region, 2017-2022 (US$ Mn)
TABLE 26 Global AI in Drug Discovery Market, by Toxicity Modeling, By Region, 2023-2030 (US$ Mn)
TABLE 27 Global AI in Drug Discovery Market, by Patient Stratification, By Region, 2017-2022 (US$ Mn)
TABLE 28 Global AI in Drug Discovery Market, by Patient Stratification, By Region, 2023-2030 (US$ Mn)
TABLE 29 Global AI in Drug Discovery Market, by Clinical Trial Optimization, By Region, 2017-2022 (US$ Mn)
TABLE 30 Global AI in Drug Discovery Market, by Clinical Trial Optimization, By Region, 2023-2030 (US$ Mn)
TABLE 31 Global AI in Drug Discovery Market, by Omics Data Integration, By Region, 2017-2022 (US$ Mn)
TABLE 32 Global AI in Drug Discovery Market, by Omics Data Integration, By Region, 2023-2030 (US$ Mn)
TABLE 33 Global AI in Drug Discovery Market, by Big Data Analytics, By Region, 2017-2022 (US$ Mn)
TABLE 34 Global AI in Drug Discovery Market, by Big Data Analytics, By Region, 2023-2030 (US$ Mn)
TABLE 35 Global AI in Drug Discovery Market, by Pharmaceutical and Biotechnology Companies, By Region, 2017-2022 (US$ Mn)
TABLE 36 Global AI in Drug Discovery Market, by Pharmaceutical and Biotechnology Companies, By Region, 2023-2030 (US$ Mn)
TABLE 37 Global AI in Drug Discovery Market, by Contract Research Organizations (CROs), By Region, 2017-2022 (US$ Mn)
TABLE 38 Global AI in Drug Discovery Market, by Contract Research Organizations (CROs), By Region, 2023-2030 (US$ Mn)
TABLE 39 Global AI in Drug Discovery Market, by Academic and Research Institutions, By Region, 2017-2022 (US$ Mn)
TABLE 40 Global AI in Drug Discovery Market, by Academic and Research Institutions, By Region, 2023-2030 (US$ Mn)
TABLE 41 Global AI in Drug Discovery Market, by Oncology, By Region, 2017-2022 (US$ Mn)
TABLE 42 Global AI in Drug Discovery Market, by Oncology, By Region, 2023-2030 (US$ Mn)
TABLE 43 Global AI in Drug Discovery Market, by Neurology, By Region, 2017-2022 (US$ Mn)
TABLE 44 Global AI in Drug Discovery Market, by Neurology, By Region, 2023-2030 (US$ Mn)
TABLE 45 Global AI in Drug Discovery Market, by Infectious Diseases, By Region, 2017-2022 (US$ Mn)
TABLE 46 Global AI in Drug Discovery Market, by Infectious Diseases, By Region, 2023-2030 (US$ Mn)
TABLE 47 Global AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 48 Global AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 49 Global AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 50 Global AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 51 Global AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 52 Global AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 53 Global AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 54 Global AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 55 Global AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 56 Global AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 57 Global AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 58 Global AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 59 Global AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 60 Global AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 61 Global AI in Drug Discovery Market, by Region, 2017-2022 (US$ Mn)
TABLE 62 Global AI in Drug Discovery Market, by Region, 2023-2030 (US$ Mn)
TABLE 63 North America AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 64 North America AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 65 North America AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 66 North America AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 67 North America AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 68 North America AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 69 North America AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 70 North America AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 71 North America AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 72 North America AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 73 North America AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 74 North America AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 75 North America AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 76 North America AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 77 North America AI in Drug Discovery Market, by Country, 2017-2022 (US$ Mn)
TABLE 78 North America AI in Drug Discovery Market, by Country, 2023-2030 (US$ Mn)
TABLE 79 United States AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 80 United States AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 81 United States AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 82 United States AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 83 United States AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 84 United States AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 85 United States AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 86 United States AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 87 United States AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 88 United States AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 89 United States AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 90 United States AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 91 United States AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 92 United States AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 93 Canada AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 94 Canada AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 95 Canada AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 96 Canada AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 97 Canada AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 98 Canada AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 99 Canada AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 100 Canada AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 101 Canada AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 102 Canada AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 103 Canada AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 104 Canada AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 105 Canada AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 106 Canada AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 107 Mexico AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 108 Mexico AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 109 Mexico AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 110 Mexico AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 111 Mexico AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 112 Mexico AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 113 Mexico AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 114 Mexico AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 115 Mexico AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 116 Mexico AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 117 Mexico AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 118 Mexico AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 119 Mexico AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 120 Mexico AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 121 Europe AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 122 Europe AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 123 Europe AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 124 Europe AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 125 Europe AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 126 Europe AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 127 Europe AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 128 Europe AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 129 Europe AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 130 Europe AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 131 Europe AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 132 Europe AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 133 Europe AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 134 Europe AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 135 Europe AI in Drug Discovery Market, by Country, 2017-2022 (US$ Mn)
TABLE 136 Europe AI in Drug Discovery Market, by Country, 2023-2030 (US$ Mn)
TABLE 137 Germany AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 138 Germany AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 139 Germany AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 140 Germany AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 141 Germany AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 142 Germany AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 143 Germany AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 144 Germany AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 145 Germany AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 146 Germany AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 147 Germany AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 148 Germany AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 149 Germany AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 150 Germany AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 151 France AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 152 France AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 153 France AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 154 France AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 155 France AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 156 France AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 157 France AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 158 France AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 159 France AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 160 France AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 161 France AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 162 France AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 163 France AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 164 France AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 165 United Kingdom AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 166 United Kingdom AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 167 United Kingdom AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 168 United Kingdom AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 169 United Kingdom AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 170 United Kingdom AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 171 United Kingdom AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 172 United Kingdom AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 173 United Kingdom AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 174 United Kingdom AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 175 United Kingdom AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 176 United Kingdom AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 177 United Kingdom AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 178 United Kingdom AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 179 Italy AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 180 Italy AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 181 Italy AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 182 Italy AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 183 Italy AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 184 Italy AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 185 Italy AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 186 Italy AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 187 Italy AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 188 Italy AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 189 Italy AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 190 Italy AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 191 Italy AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 192 Italy AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 193 Spain AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 194 Spain AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 195 Spain AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 196 Spain AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 197 Spain AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 198 Spain AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 199 Spain AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 200 Spain AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 201 Spain AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 202 Spain AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 203 Spain AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 204 Spain AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 205 Spain AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 206 Spain AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 207 Benelux AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 208 Benelux AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 209 Benelux AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 210 Benelux AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 211 Benelux AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 212 Benelux AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 213 Benelux AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 214 Benelux AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 215 Benelux AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 216 Benelux AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 217 Benelux AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 218 Benelux AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 219 Benelux AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 220 Benelux AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 221 Russia AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 222 Russia AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 223 Russia AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 224 Russia AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 225 Russia AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 226 Russia AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 227 Russia AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 228 Russia AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 229 Russia AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 230 Russia AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 231 Russia AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 232 Russia AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 233 Russia AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 234 Russia AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 235 Rest of Europe AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 236 Rest of Europe AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 237 Rest of Europe AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 238 Rest of Europe AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 239 Rest of Europe AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 240 Rest of Europe AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 241 Rest of Europe AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 242 Rest of Europe AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 243 Rest of Europe AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 244 Rest of Europe AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 245 Rest of Europe AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 246 Rest of Europe AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 247 Rest of Europe AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 248 Rest of Europe AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 249 Asia Pacific AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 250 Asia Pacific AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 251 Asia Pacific AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 252 Asia Pacific AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 253 Asia Pacific AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 254 Asia Pacific AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 255 Asia Pacific AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 256 Asia Pacific AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 257 Asia Pacific AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 258 Asia Pacific AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 259 Asia Pacific AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 260 Asia Pacific AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 261 Asia Pacific AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 262 Asia Pacific AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 263 China AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 264 China AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 265 China AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 266 China AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 267 China AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 268 China AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 269 China AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 270 China AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 271 China AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 272 China AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 273 China AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 274 China AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 275 China AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 276 China AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 277 Japan AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 278 Japan AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 279 Japan AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 280 Japan AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 281 Japan AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 282 Japan AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 283 Japan AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 284 Japan AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 285 Japan AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 286 Japan AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 287 Japan AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 288 Japan AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 289 Japan AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 290 Japan AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 291 India AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 292 India AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 293 India AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 294 India AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 295 India AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 296 India AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 297 India AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 298 India AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 299 India AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 300 India AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 301 India AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 302 India AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 303 India AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 304 India AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 305 South Korea AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 306 South Korea AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 307 South Korea AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 308 South Korea AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 309 South Korea AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 310 South Korea AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 311 South Korea AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 312 South Korea AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 313 South Korea AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 314 South Korea AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 315 South Korea AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 316 South Korea AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 317 South Korea AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 318 South Korea AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 319 South-East Asia AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 320 South-East Asia AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 321 South-East Asia AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 322 South-East Asia AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 323 South-East Asia AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 324 South-East Asia AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 325 South-East Asia AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 326 South-East Asia AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 327 South-East Asia AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 328 South-East Asia AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 329 South-East Asia AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 330 South-East Asia AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 331 South-East Asia AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 332 South-East Asia AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 333 Rest of Asia Pacific AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 334 Rest of Asia Pacific AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 335 Rest of Asia Pacific AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 336 Rest of Asia Pacific AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 337 Rest of Asia Pacific AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 338 Rest of Asia Pacific AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 339 Rest of Asia Pacific AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 340 Rest of Asia Pacific AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 341 Rest of Asia Pacific AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 342 Rest of Asia Pacific AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 343 Rest of Asia Pacific AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 344 Rest of Asia Pacific AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 345 Rest of Asia Pacific AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 346 Rest of Asia Pacific AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 347 Latin America AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 348 Latin America AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 349 Latin America AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 350 Latin America AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 351 Latin America AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 352 Latin America AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 353 Latin America AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 354 Latin America AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 355 Latin America AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 356 Latin America AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 357 Latin America AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 358 Latin America AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 359 Latin America AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 360 Latin America AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 361 Brazil AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 362 Brazil AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 363 Brazil AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 364 Brazil AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 365 Brazil AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 366 Brazil AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 367 Brazil AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 368 Brazil AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 369 Brazil AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 370 Brazil AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 371 Brazil AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 372 Brazil AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 373 Brazil AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 374 Brazil AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 375 Argentina AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 376 Argentina AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 377 Argentina AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 378 Argentina AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 379 Argentina AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 380 Argentina AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 381 Argentina AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 382 Argentina AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 383 Argentina AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 384 Argentina AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 385 Argentina AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 386 Argentina AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 387 Argentina AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 388 Argentina AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 389 Rest of Latin America AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 390 Rest of Latin America AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 391 Rest of Latin America AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 392 Rest of Latin America AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 393 Rest of Latin America AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 394 Rest of Latin America AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 395 Rest of Latin America AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 396 Rest of Latin America AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 397 Rest of Latin America AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 398 Rest of Latin America AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 399 Rest of Latin America AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 400 Rest of Latin America AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 401 Rest of Latin America AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 402 Rest of Latin America AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 403 Middle East AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 404 Middle East AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 405 Middle East AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 406 Middle East AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 407 Middle East AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 408 Middle East AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 409 Middle East AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 410 Middle East AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 411 Middle East AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 412 Middle East AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 413 Middle East AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 414 Middle East AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 415 Middle East AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 416 Middle East AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 417 UAE AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 418 UAE AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 419 UAE AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 420 UAE AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 421 UAE AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 422 UAE AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 423 UAE AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 424 UAE AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 425 UAE AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 426 UAE AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 427 UAE AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 428 UAE AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 429 UAE AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 430 UAE AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 431 Saudi Arabia AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 432 Saudi Arabia AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 433 Saudi Arabia AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 434 Saudi Arabia AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 435 Saudi Arabia AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 436 Saudi Arabia AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 437 Saudi Arabia AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 438 Saudi Arabia AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 439 Saudi Arabia AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 440 Saudi Arabia AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 441 Saudi Arabia AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 442 Saudi Arabia AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 443 Saudi Arabia AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 444 Saudi Arabia AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 445 Rest of Middle East AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 446 Rest of Middle East AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 447 Rest of Middle East AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 448 Rest of Middle East AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 449 Rest of Middle East AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 450 Rest of Middle East AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 451 Rest of Middle East AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 452 Rest of Middle East AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 453 Rest of Middle East AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 454 Rest of Middle East AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 455 Rest of Middle East AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 456 Rest of Middle East AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 457 Rest of Middle East AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 458 Rest of Middle East AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 459 Africa AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 460 Africa AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 461 Africa AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 462 Africa AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 463 Africa AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 464 Africa AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 465 Africa AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 466 Africa AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 467 Africa AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 468 Africa AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 469 Africa AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 470 Africa AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 471 Africa AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 472 Africa AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 473 South Africa AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 474 South Africa AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 475 South Africa AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 476 South Africa AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 477 South Africa AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 478 South Africa AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 479 South Africa AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 480 South Africa AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 481 South Africa AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 482 South Africa AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 483 South Africa AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 484 South Africa AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 485 South Africa AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 486 South Africa AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 487 Egypt AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 488 Egypt AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 489 Egypt AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 490 Egypt AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 491 Egypt AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 492 Egypt AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 493 Egypt AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 494 Egypt AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 495 Egypt AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 496 Egypt AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 497 Egypt AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 498 Egypt AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 499 Egypt AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 500 Egypt AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)
TABLE 501 Rest of Africa AI in Drug Discovery Market, by Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 502 Rest of Africa AI in Drug Discovery Market, by Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 503 Rest of Africa AI in Drug Discovery Market, by Compound Screening and Design, 2017-2022 (US$ Mn)
TABLE 504 Rest of Africa AI in Drug Discovery Market, by Compound Screening and Design, 2023-2030 (US$ Mn)
TABLE 505 Rest of Africa AI in Drug Discovery Market, by ADME-Tox Prediction, 2017-2022 (US$ Mn)
TABLE 506 Rest of Africa AI in Drug Discovery Market, by ADME-Tox Prediction, 2023-2030 (US$ Mn)
TABLE 507 Rest of Africa AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2017-2022 (US$ Mn)
TABLE 508 Rest of Africa AI in Drug Discovery Market, by Clinical Trial Design and Patient Selection, By Region, 2023-2030 (US$ Mn)
TABLE 509 Rest of Africa AI in Drug Discovery Market, by Data Integration and Analysis, 2017-2022 (US$ Mn)
TABLE 510 Rest of Africa AI in Drug Discovery Market, by Data Integration and Analysis, 2023-2030 (US$ Mn)
TABLE 511 Rest of Africa AI in Drug Discovery Market, by End-User, 2017-2022 (US$ Mn)
TABLE 512 Rest of Africa AI in Drug Discovery Market, by End-User, 2023-2030 (US$ Mn)
TABLE 513 Rest of Africa AI in Drug Discovery Market, by Application Area, 2017-2022 (US$ Mn)
TABLE 514 Rest of Africa AI in Drug Discovery Market, by Application Area, 2023-2030 (US$ Mn)

What is the current size of the global AI in the drug discovery market?

The global AI in drug discovery market was valued at USD 1684.5 Million in 2022.

What is the expected growth rate of AI in the drug discovery market between 2023 and 2030?

The AI in the drug discovery market is expected to grow at a CAGR of 30.8% between 2023 and 2030, reaching USD 14432.2 Million in 2030.

Which segment is leading the market share in terms of application area?

Oncology is the leading segment by application area, holding over 38% share in value in 2022.

Which end-user category governs the global demand for AI in drug discovery?

The pharmaceutical and biotechnology companies govern the global demand for AI in drug discovery, holding a massive market share of over 40% in 2022.

Which compound screening and design category will post the highest market CAGR?

The generative chemistry segment will post the fastest CAGR over the projection period.

Which region is fueling the growth of AI in the drug discovery industry?

North America is fueling the robust growth of AI in the drug discovery industry, with over one-third of its global market share in 2022.

Who are the main players in the global AI in drug discovery market?

The top players include Microsoft, BenevolentAI, Excientia, IBM Corporation, Alphabet (DeepMind), and Others.

Qatar Dental Care Market

Published:
Report ID: 30608

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market

Published:
Report ID: 33712

Tracheitis Treatment Market

Published:
Report ID: 33694

Neuralgia Treatment Market

Published:
Report ID: 33681

Clostridioides Difficile (C. diff) Treatment Market

Published:
Report ID: 33667

Hepatic Encephalopathy Market

Published:
Report ID: 33664

Sphingosine-1-Receptor Modulators Drugs Market

Published:
Report ID: 33649

Guidewires Market

Published:
Report ID: 6790

3D Printing for Personalized Healthcare Market

Published:
Report ID: 33603

Neuromyelitis Optica Therapy Market

Published:
Report ID: 33583

In Vitro Diagnostic (IVD) Kit Market

Published:
Report ID: 33580

North America Medical Headgears Market

Published:
Report ID: 33554

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN